Defining high HIV incidence subgroups of Australian homosexual men: implications for conducting HIV prevention trials in low HIV prevalence settings.

作者: IM Poynten , F Jin , GP Prestage , JM Kaldor , S Kippax

DOI: 10.1111/J.1468-1293.2010.00833.X

关键词:

摘要: Objectives The aim of the study was to assess whether subpopulations with sufficiently high HIV incidences for prevention trials can be identified in low incidence settings such as Australia. Methods In a community-based cohort HIV-negative homosexually active men Sydney, Australia, potential risk factors associated an annual ≥2 per 100 person-years (PY) were identified. A stepwise procedure ranked these according incidence, create ‘high-incidence’ subgroup participants. Willingness participate assessed. Results Although overall only 0.78 PY, nine variables 2 PY or greater. Stepwise inclusion revealed representing 24% total follow-up time combined 2.71 who reported at least one three past 6 months. These more willing than others vaccine and antiretroviral therapy trials. Conclusions These findings demonstrate that it is possible identify low-incidence are above average willingness trials.

参考文章(38)
Anthony D Kelleher, Rebekah L Puls, Mark Bebbington, David Boyle, Rosemary Ffrench, Stephen J Kent, Sue Kippax, Damian FJ Purcell, Scott Thomson, Handan Wand, David A Cooper, Sean Emery, None, A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1 AIDS. ,vol. 20, pp. 294- 297 ,(2006) , 10.1097/01.AIDS.0000199819.40079.E9
Janneke van de Wijgert, Heidi Jones, Challenges in microbicide trial design and implementation. Studies in Family Planning. ,vol. 37, pp. 123- 129 ,(2006) , 10.1111/J.1728-4465.2006.00091.X
Leigh Peterson, Kavita Nanda, Baafuor Kofi Opoku, William Kwabena Ampofo, Margaret Owusu-Amoako, Andrew Yiadom Boakye, Wes Rountree, Amanda Troxler, Rosalie Dominik, Ronald Roddy, Laneta Dorflinger, SAVVY® (C31G) Gel for Prevention of HIV infection in Women: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Ghana PLoS ONE. ,vol. 2, pp. e1312- ,(2007) , 10.1371/JOURNAL.PONE.0001312
David J Templeton, Fengyi Jin, Garrett P Prestage, Basil Donovan, John C Imrie, Susan C Kippax, Phillip H Cunningham, John M Kaldor, Adrian Mindel, Anthony L Cunningham, Andrew E Grulich, None, Circumcision and risk of sexually transmissible infections in a community-based cohort of HIV-negative homosexual men in Sydney, Australia. The Journal of Infectious Diseases. ,vol. 200, pp. 1813- 1819 ,(2009) , 10.1086/648376
Gaston Djomand, Barbara Metch, Carmen D Zorrilla, Yeycy Donastorg, Martin Casapia, Tonya Villafana, Jean Pape, Peter Figueroa, Marianne Hansen, Susan Buchbinder, Chris Beyrer, The HVTN protocol 903 vaccine preparedness study: lessons learned in preparation for HIV vaccine efficacy trials. Journal of Acquired Immune Deficiency Syndromes. ,vol. 48, pp. 82- 89 ,(2008) , 10.1097/QAI.0B013E31817236AB
Lut Van Damme, Roshini Govinden, Florence M Mirembe, Fernand Guédou, Suniti Solomon, Marissa L Becker, BS Pradeep, AK Krishnan, Michel Alary, Bina Pande, Gita Ramjee, Jennifer Deese, Tania Crucitti, Doug Taylor, None, Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. The New England Journal of Medicine. ,vol. 359, pp. 463- 472 ,(2008) , 10.1056/NEJMOA0707957
S K Hira, P J Feldblum, J Kamanga, G Mukelabai, S S Weir, J C Weir, Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia. International Journal of Std & Aids. ,vol. 8, pp. 243- 250 ,(1997) , 10.1258/0956462971919994
Nancy S Padian, Anne Buvé, Jennifer Balkus, David Serwadda, Ward Cates, Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward The Lancet. ,vol. 372, pp. 585- 599 ,(2008) , 10.1016/S0140-6736(08)60885-5
Leopold Zekeng, Paul J. Feldblum, Regina M. Oliver, Lazare Kaptue, Barrier contraceptive use and HIV infection among high-risk women in Cameroon. AIDS. ,vol. 7, pp. 725- 731 ,(1993) , 10.1097/00002030-199305000-00018
Clayton D Harro, Franklyn N Judson, Geoffrey J Gorse, Kenneth H Mayer, Jay R Kostman, Stephen J Brown, Beryl Koblin, Michael Marmor, Bradford N Bartholow, Vladimir Popovic, VAX004 Study Group, None, Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial Journal of Acquired Immune Deficiency Syndromes. ,vol. 37, pp. 1385- 1392 ,(2004) , 10.1097/01.QAI.0000122983.87519.B5